Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Evolving Immunotherapy Approaches for Renal Cell Carcinoma
Susanna A. Curtis
, Justine V. Cohen
, Harriet M. Kluger
Research output
:
Contribution to journal
›
Review article
›
peer-review
28
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evolving Immunotherapy Approaches for Renal Cell Carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Renal Cell Carcinoma
100%
Immune Therapy
100%
Immune System
50%
Progression-free Survival
50%
Metastatic Renal Cell Carcinoma (mRCC)
50%
Cell Therapy
50%
Survival Response
50%
Overall Survival
50%
Targeted Therapy
50%
Vaccine Therapy
50%
Prolonged Survival
50%
Cytotoxic Chemotherapy
50%
Therapy Approaches
50%
Cytokine Therapy
50%
Checkpoint Inhibitors
50%
Combination of Therapies
50%
Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Immunotherapy
100%
Immune System
33%
Progression Free Survival
33%
Overall Survival
33%
Hope
33%
Kidney Metastasis
33%
Targeted Therapy
33%
Cell Therapy
33%
Cytotoxic Chemotherapy
33%
Cytokine Therapy
33%